manufacturing four (4) mg Aza-TdC Capsules
$71,645N02FY2019CANIH
Irisys, Inc., San Diego CA
Investigators
Abstract
PRODUCTION OF 4 MG AZA-TDC CAPSULES FOR CLINICAL USE. The batch of product was produced by the contractor and sent to clinical repository. The shelf-life was also evaluated. The drug product will be used in the NCI clinical trials.
View original record on NIH RePORTER →